✉news HealthNutrition first seen 4 h ago, last 4 h ago, peak #8
Blood metabolites may signal triple-negative breast cancer risk
Original: Prospective analysis of pre-diagnostic untargeted plasma metabolomics and risk of triple-negative breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Researchers with the International Agency for Research on Cancer have published a prospective study analysing pre-diagnostic plasma metabolomics and the risk of triple-negative breast cancer within the European Prospective Investigation into Cancer and Nutrition (EPIC). The work examines whether metabolic signatures measured in blood before diagnosis are associated with later development of this aggressive breast cancer subtype. Details on the strength of the findings were not provided.
Why now: A new IARC study on blood markers predicting an aggressive breast cancer subtype has just been published, drawing attention from cancer research and nutrition audiences.
International Agency for Research on CancerEPICtriple-negative breast cancer
Evidence
- Prospective analysis of pre-diagnostic untargeted plasma metabolomics and risk of triple-negative breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) · International Agency for Research on Cancer (IARC)
API: https://socialmediatrends-api.osmike.com/v1/trends/615614